Table 3.
Reduction in Peak INa Following Perfusion of 4,9-ah-TTX | ||||
---|---|---|---|---|
[4,9-ah-TTX] | (% of Control) | |||
Nav 1.1 | N | Nav 1.6 | N | |
10nM | 11 % (± 4) | 4 | 18 % ( ±2) | 4 |
100nM | 46 % ( ± 5) | 5 | 39 % ( ±2) | 4 |
500 nM | 64 % ( ± 4) | 5 | 76 % ( ±2) | 3 |
Reduction in Peak INa Following Perfusion of 4,9-ah-TTX | ||||
---|---|---|---|---|
[4,9-ah-TTX] | (% of Control) | |||
Nav 1.1 | N | Nav 1.6 | N | |
10nM | 11 % (± 4) | 4 | 18 % ( ±2) | 4 |
100nM | 46 % ( ± 5) | 5 | 39 % ( ±2) | 4 |
500 nM | 64 % ( ± 4) | 5 | 76 % ( ±2) | 3 |